Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 4
2005 8
2006 4
2007 3
2008 5
2010 4
2011 5
2012 7
2013 8
2014 2
2015 5
2016 3
2017 6
2018 7
2019 8
2020 16
2021 23
2022 22
2023 22
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Overview of autoantibodies in COVID-19 convalescents.
Dobrowolska K, Zarębska-Michaluk D, Poniedziałek B, Jaroszewicz J, Flisiak R, Rzymski P. Dobrowolska K, et al. Among authors: jaroszewicz j. J Med Virol. 2023 Jun;95(6):e28864. doi: 10.1002/jmv.28864. J Med Virol. 2023. PMID: 37310140 Review.
Gene-Editing and RNA Interference in Treating Hepatitis B: A Review.
Kasianchuk N, Dobrowolska K, Harkava S, Bretcan A, Zarębska-Michaluk D, Jaroszewicz J, Flisiak R, Rzymski P. Kasianchuk N, et al. Among authors: jaroszewicz j. Viruses. 2023 Dec 8;15(12):2395. doi: 10.3390/v15122395. Viruses. 2023. PMID: 38140636 Free PMC article. Review.
Immunosenescence and multiple sclerosis.
Adamczyk-Sowa M, Nowak-Kiczmer M, Jaroszewicz J, Berger T. Adamczyk-Sowa M, et al. Among authors: jaroszewicz j. Neurol Neurochir Pol. 2022;56(3):220-227. doi: 10.5603/PJNNS.a2022.0045. Epub 2022 Jun 23. Neurol Neurochir Pol. 2022. PMID: 35735245 Free article.
Recommendations for the treatment of hepatitis B in 2017.
Polish Group of Experts for HBV; Flisiak R, Halota W, Jaroszewicz J, Juszczyk J, Małkowski P, Pawłowska M, Piekarska A, Simon K, Tomasiewicz K, Wawrzynowicz-Syczewska M. Polish Group of Experts for HBV, et al. Among authors: jaroszewicz j. Clin Exp Hepatol. 2017 Jun;3(2):35-46. doi: 10.5114/ceh.2017.67626. Epub 2017 May 10. Clin Exp Hepatol. 2017. PMID: 28856289 Free PMC article. Review.
siRNA drug development against hepatitis B virus infection.
Flisiak R, Jaroszewicz J, Łucejko M. Flisiak R, et al. Among authors: jaroszewicz j. Expert Opin Biol Ther. 2018 Jun;18(6):609-617. doi: 10.1080/14712598.2018.1472231. Epub 2018 May 8. Expert Opin Biol Ther. 2018. PMID: 29718723 Review.
Emerging treatments for hepatitis C.
Flisiak R, Jaroszewicz J, Parfieniuk-Kowerda A. Flisiak R, et al. Among authors: jaroszewicz j. Expert Opin Emerg Drugs. 2013 Dec;18(4):461-75. doi: 10.1517/14728214.2013.847089. Epub 2013 Oct 8. Expert Opin Emerg Drugs. 2013. PMID: 24102413 Review.
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, Benetti E, Amitrano S, Bruttini M, Palmieri M, Croci S, Lista M, Beligni G, Valentino F, Meloni I, Tanfoni M, Minnai F, Colombo F, Cabri E, Fratelli M, Gabbi C, Mantovani S, Frullanti E, Gori M, Crawley FP, Butler-Laporte G, Richards B, Zeberg H, Lipcsey M, Hultström M, Ludwig KU, Schulte EC, Pairo-Castineira E, Baillie JK, Schmidt A, Frithiof R; WES/WGS Working Group Within the HGI; GenOMICC Consortium; GEN-COVID Multicenter Study; Mari F, Renieri A, Furini S. Fallerini C, et al. Hum Genet. 2022 Jan;141(1):147-173. doi: 10.1007/s00439-021-02397-7. Epub 2021 Dec 10. Hum Genet. 2022. PMID: 34889978 Free PMC article.
153 results